Home About Us Our Vision Our Team Portfolio Inv. Relations News Contact Us

Click here to view all of Teuza's portfolio companies (print version - pdf format)



A private U.S. company in which Teuza holds 3%.

Bioness Holds 100% of Ness Neuromuscular Electrical Stimulation Systems (“N.E.S.S."), which is a private company located in Israel. NESS changed its name to Bioness Neuromodulation Ltd. (“Bioness Israel”).

Bioness brings to the market a revolution in rehabilitation technology. It provides technological solutions that respond to the needs of people suffering from paralysis due to neurological disorders such as stroke, spinal cord and/or head injury, and in some other neurological indications including cerebral palsy and multiple sclerosis. Experts expect that the Company's products will become a standard of care in the rehabilitation field within a few years.

The company uses the technology of surface functional electrical stimulation (FES) to develop solutions for activating paralyzed muscles. The systems are designed for home use and provide the potential of enhanced function and therapeutically based improvement.

The company's first product, the HS200, is a non-invasive system for paralyzed hands. The HS200 system received the CE mark & approved by the FDA for marketing in the U.S.A. The HS200 personal system incorporates and integrates advanced upper limb rehabilitation technologies in a single system for patients' independent use. Bioness Israel has applied this successful rehabilitation concept in other body sites, to offer a full range of products for a comprehensive treatment of the paralyzed body.

The leg device, NESS L300, received the CE mark & approved by the FDA for marketing in the U.S.A. The NESS L300 is intended to provide ankle dorsiflexion in individuals with drop foot following an upper motor neuron injury or disease. The leg device is makes a revolution in the rehabilitation field and enables paralyzed people to walk.

Bioness also develops a unique product in the rehabilitation field- a “Stim Router”, which is an implant sensor connected to the neurons, which is used as a receptor for electric stimulating waves.In 2015 the Stim Router received FDA approval.

P.O.B 25266 Haifa 31250 Israel Tel: 972 4 8728788 Fax: 972 4 8729393 E-mail: teuza@teuzafund.com